Antimicrobial Drugs: Mechanisms, Clinical Considerations, and Resistance

History and Types of Antimicrobial Agents

Introduction to Antimicrobial Agents

Antimicrobial agents are chemicals used to treat infections by inhibiting or killing microorganisms. Their development revolutionized medicine, enabling effective treatment of bacterial, fungal, and viral diseases.

• Chemotherapeutic agents: Drugs that act against diseases, including infections.

• Antimicrobial agents: Drugs specifically used to treat infections.

• Antibiotics: Naturally produced antimicrobial agents by organisms, especially bacteria and fungi.

• Semi-synthetics: Chemically modified antibiotics for improved efficacy.

• Synthetics: Completely synthesized antimicrobials in laboratories.

Historical Figures in Antimicrobial Discovery

• Paul Ehrlich: Developed arsenic compounds as "magic bullets" to kill microbes.

• Alexander Fleming: Discovered penicillin from Penicillium mold.

• Gerhard Domagk: Discovered sulfanilamide, a synthetic antimicrobial.

• Selman Waksman: Coined the term "antibiotics" for naturally produced antimicrobial agents.

Example: Antibiotic Effect of Penicillium

The discovery of penicillin demonstrated the ability of mold to inhibit bacterial growth, as seen in the classic experiment with Penicillium chrysogenum and Staphylococcus aureus.

Mechanisms of Antimicrobial Action

Overview of Mechanisms

Antimicrobial drugs act through several distinct mechanisms, targeting specific structures or processes in microorganisms. Selective toxicity is key, aiming to harm pathogens without damaging host cells.

• Inhibition of cell wall synthesis

• Inhibition of protein synthesis

• Disruption of cytoplasmic membranes

• Inhibition of metabolic pathways

• Inhibition of nucleic acid synthesis

• Prevention of virus attachment

Inhibition of Cell Wall Synthesis

Many antibacterial agents target the synthesis of peptidoglycan, a key component of bacterial cell walls.

• Beta-lactams: Bind to enzymes that cross-link NAM subunits, weakening the cell wall and causing lysis.

• Vancomycin and cycloserine: Interfere with bridges linking NAM subunits in Gram-positive bacteria.

• Bacitracin: Blocks secretion of NAG and NAM from the cytoplasm.

• Isoniazid and ethambutol: Disrupt mycolic acid formation in mycobacteria.

Peptidoglycan Structure and Growth

The bacterial cell wall is composed of NAG-NAM chains cross-linked by peptides. New subunits are inserted during growth, and antibiotics can prevent this process.

Inhibition of Protein Synthesis

Antimicrobials can selectively target prokaryotic ribosomes (70S), inhibiting translation and thus protein synthesis.

• Aminoglycosides: Cause misreading of mRNA.

• Tetracyclines: Block docking site of tRNA.

• Chloramphenicol: Inhibits peptide bond formation.

• Macrolides and lincosamides: Block movement of ribosome.

Disruption of Cytoplasmic Membranes

Some drugs damage the integrity of microbial membranes, leading to cell death.

• Amphotericin B: Binds to ergosterol in fungal membranes, forming pores.

• Azoles and allyamines: Inhibit ergosterol synthesis.

• Polymyxin: Disrupts membranes of Gram-negative bacteria; toxic to human kidneys.

Inhibition of Metabolic Pathways

Antimetabolic agents block unique metabolic processes in pathogens.

• Quinolones: Interfere with malaria parasite metabolism.

• Heavy metals: Inactivate enzymes.

• Sulfonamides: Block folic acid synthesis in bacteria and protozoa.

• Antiviral agents: Target viral metabolism, e.g., amantadine prevents viral uncoating.

Inhibition of Nucleic Acid Synthesis

Drugs can block DNA replication or mRNA transcription, often affecting both prokaryotic and eukaryotic cells.

• Nucleotide analogs: Distort nucleic acid shapes, preventing replication and transcription.

• Quinolones and fluoroquinolones: Inhibit DNA gyrase in prokaryotes.

• Reverse transcriptase inhibitors: Target HIV replication.

Prevention of Virus Attachment

• Attachment antagonists: Block viral attachment or receptor proteins, preventing infection.

Clinical Considerations in Prescribing Antimicrobial Drugs

Ideal Antimicrobial Agent

The ideal drug is readily available, inexpensive, chemically stable, easily administered, nontoxic, nonallergenic, and selectively toxic against a wide range of pathogens.

Spectrum of Action

• Narrow-spectrum: Effective against a few organisms.

• Broad-spectrum: Effective against many organisms; may cause secondary infections or superinfections by killing normal flora.

Efficacy Testing

Efficacy is determined by laboratory tests:

• Diffusion susceptibility test: Measures zone of inhibition.

• Minimum inhibitory concentration (MIC) test: Determines lowest concentration preventing growth.

• Minimum bactericidal concentration (MBC) test: Determines lowest concentration killing bacteria.

Routes of Administration

• Topical: For external infections.

• Oral: Self-administered, no needles.

• Intramuscular: Injection into muscle.

• Intravenous: Directly into bloodstream.

Safety and Side Effects

• Toxicity: May affect kidneys, liver, or nerves; special consideration for pregnant women.

• Allergies: Rare but potentially life-threatening (anaphylactic shock).

• Disruption of normal microbiota: Can lead to secondary infections or superinfections, especially in hospitalized patients.

Resistance to Antimicrobial Drugs

Development of Resistance

Resistance arises naturally or is acquired through mutations or horizontal gene transfer (R-plasmids via transformation, transduction, or conjugation).

Mechanisms of Resistance

Microbes resist drugs by:

• Producing enzymes that destroy or deactivate drugs (e.g., β-lactamase).

• Preventing drug entry into the cell.

• Altering drug targets.

• Changing metabolic pathways.

• Pumping drugs out of the cell.

• Producing proteins that protect targets (e.g., MfpA protein in Mycobacterium tuberculosis).

Multiple Resistance and Cross Resistance

• Pathogens may acquire resistance to multiple drugs, especially in hospital settings.

• Cross resistance occurs when resistance to one drug confers resistance to similar drugs.

• Superbugs are highly resistant strains.

Retarding Resistance

Strategies to slow resistance include:

• Maintaining high drug concentrations to kill sensitive cells.

• Using drug combinations (synergism vs. antagonism).

• Limiting antimicrobial use to necessary cases.

• Developing new drugs and variations (second- and third-generation drugs).

• Designing drugs to target unique microbial proteins.

Summary Table: Mechanisms of Antimicrobial Action

Mechanism	Example Drugs	Target
Inhibition of Cell Wall Synthesis	Penicillins, Cephalosporins, Vancomycin	Peptidoglycan
Inhibition of Protein Synthesis	Aminoglycosides, Tetracyclines, Macrolides	Ribosomes
Disruption of Cytoplasmic Membrane	Polymyxin, Amphotericin B	Membrane integrity
Inhibition of Metabolic Pathways	Sulfonamides, Trimethoprim	Enzymes/metabolism
Inhibition of Nucleic Acid Synthesis	Quinolones, Nucleotide analogs	DNA/RNA
Prevention of Virus Attachment	Arildone, Pleconaril	Viral receptors

Key Equations and Concepts

Minimum Inhibitory Concentration (MIC)

The MIC is the lowest concentration of an antimicrobial that prevents visible growth of a microorganism.

$\text{MIC} = \min \{ c : \text{no visible growth at concentration } c \}$

Minimum Bactericidal Concentration (MBC)

The MBC is the lowest concentration of an antimicrobial that kills 99.9% of the original inoculum.

$\text{MBC} = \min \{ c : \text{no colony formation at concentration } c \}$

Zone of Inhibition

The diameter of the zone of inhibition in a diffusion test correlates with drug efficacy.

$\text{Zone of Inhibition} \propto \text{Drug Diffusion and Susceptibility}$

----------------------------------------